Datamonitor Healthcare: data analysis and insight
Explore the key hurdles to anticipating the initial and potential value of the NASH therapy market.
Informa Pharma Intelligence presents an essential, free session during which industry analysts present their data-driven views about what to expect during the third quarter of 2019. Using their extensive experience, supported by data from Datamonitor Healthcare, Biomedtracker, and Pharmapremia, the analysts will examine:
Biomedtracker: follow the drug development process
What were the outcomes of critical catalysts featured in Biomedtracker’s Q3 2019 Outlook Report? Find out in the Catalyst Roundup: A Review of Select Catalysts from Last Quarter’s Outlook Report. This data-rich graphic is available now – for free.
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: